KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 192 filers reported holding KITE PHARMA INC in Q4 2016. The put-call ratio across all filers is 2.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $719,127,000 | +34.7% | 6,936,691 | +1.9% | 0.22% | +33.9% |
| Q1 2017 | $534,069,000 | +94.9% | 6,804,291 | +11.4% | 0.17% | +88.8% |
| Q4 2016 | $273,962,000 | -19.3% | 6,109,771 | +0.6% | 0.09% | -20.5% |
| Q3 2016 | $339,384,000 | +12.9% | 6,075,623 | +1.0% | 0.11% | +8.7% |
| Q2 2016 | $300,723,000 | +9.5% | 6,014,453 | +0.5% | 0.10% | +8.4% |
| Q1 2016 | $274,668,000 | -25.0% | 5,982,753 | +0.7% | 0.10% | -24.0% |
| Q4 2015 | $365,995,000 | +22.7% | 5,939,553 | +10.9% | 0.12% | +16.8% |
| Q3 2015 | $298,303,000 | -10.8% | 5,357,460 | -2.3% | 0.11% | -2.7% |
| Q2 2015 | $334,401,000 | +13.1% | 5,484,685 | +7.0% | 0.11% | +8.9% |
| Q1 2015 | $295,603,000 | +32.9% | 5,124,885 | +32.9% | 0.10% | +32.9% |
| Q4 2014 | $222,442,000 | +239.6% | 3,857,147 | +61.4% | 0.08% | +230.4% |
| Q3 2014 | $65,505,000 | – | 2,389,185 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|